These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 5873262)

  • 1. [Complete remissions and current treatment of acute leukemia].
    Bernard J
    Probl Gematol Pereliv Krovi; 1965 Nov; 10(11):3-9. PubMed ID: 5873262
    [No Abstract]   [Full Text] [Related]  

  • 2. [The mechanism of the emergence of hematological remissions (on the problem of tumor regression)].
    Alekseev GA
    Ter Arkh; 1968 Apr; 40(4):16-25. PubMed ID: 5740509
    [No Abstract]   [Full Text] [Related]  

  • 3. [Histological lesions of the bone marrow during the initial period of acute leukemia in adults. Study by marrow biopsy].
    Duhamel G
    Nouv Rev Fr Hematol; 1965; 5(5):769-71. PubMed ID: 4221305
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of leukemia].
    Huth E
    Arch Kinderheilkd; 1968; 178(1):1-8. PubMed ID: 5718972
    [No Abstract]   [Full Text] [Related]  

  • 5. Current therapy of acute leukoses and myelosuppressive effect of cytostatics in the course of treatment.
    Hauptmann E
    Lijec Vjesn; 1978 Jun; 100(6):376. PubMed ID: 703494
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical usefulness of eticholanolone in the evaluation of bone marrow reserves in patients treated with myelosuppressive drugs and with radiotherapy].
    Marcolongo R; Di Paolo N; Bianco G; Bravi A
    Haematologica; 1969; 54(9):603-26. PubMed ID: 4994340
    [No Abstract]   [Full Text] [Related]  

  • 7. AMSA--a promising new agent in refractory acute leukemia.
    Lawrence HJ; Ries CA; Reynolds RD; Lewis JP; Koretz MM; Torti FM
    Cancer Treat Rep; 1982 Jul; 66(7):1475-8. PubMed ID: 7046928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. I have good news! You have leukemia.
    Kurzrock R
    Clin Dermatol; 2007; 25(3):350-2. PubMed ID: 17560314
    [No Abstract]   [Full Text] [Related]  

  • 9. Minimal residual disease in hairy-cell leukemia after treatment with 2-chlorodeoxyadenosine.
    Konwalinka G; Schirmer M; Hilbe W; Fend F; Geisen F; Knoblechner A; Petzer A; Thaler J
    Blood Cells Mol Dis; 1995; 21(2):142-51. PubMed ID: 8846043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Methods of evaluating residual disease in bone marrow in malignant hemopathies. Prospectives].
    Hervé P; Favrot M
    Nouv Rev Fr Hematol (1978); 1987; 29(2):103-6. PubMed ID: 3302940
    [No Abstract]   [Full Text] [Related]  

  • 11. Correctly recognizing leukemic cells in bone marrow in infants: importance of good training in hematological morphology.
    Anand M; Kumar R; Ghara N; Thavaraj V
    Indian J Pathol Microbiol; 2005 Jul; 48(3):420-1. PubMed ID: 16761778
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of image analysis and immunostaining of bone marrow trephine biopsy specimens to quantify residual disease in patients with B-cell chronic lymphocytic leukemia.
    Gala JL; Guiot Y; Delannoy A; Scheiff JM; Philippe M; Martiat P
    Mod Pathol; 1999 Apr; 12(4):391-9. PubMed ID: 10229504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
    Betticher DC; Huxol H; Müller R; Speck B; Nissen C
    Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [3 cases of bone marrow necrosis in acute leukemia].
    Montemayor-Montoya JL; De León-Cantú RE; Gómez-Almaguer D; Herrera-Garza JL
    Rev Invest Clin; 1997; 49(4):295-8. PubMed ID: 9707995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bone marrow changes in patients with hairy cell leukemia after 2-chlorodeoxyadenosine treatment].
    Urasiński I; Zdziarska B; Krygier-Stojałowska A
    Acta Haematol Pol; 1996; 27(1):49-55. PubMed ID: 8629443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Extremely undifferentiated acute erythremic myelosis].
    Drescher J; Leder LD
    Z Kinderheilkd; 1970; 108(2):117-37. PubMed ID: 5281035
    [No Abstract]   [Full Text] [Related]  

  • 18. The treatment of acute nonlymphoblastic leukemia in adults.
    Arlin ZA; Clarkson BD
    Adv Intern Med; 1983; 28():303-23. PubMed ID: 6404130
    [No Abstract]   [Full Text] [Related]  

  • 19. m-AMSA: phase II trial in advanced lymphoma and leukemia.
    Case DC
    Am J Clin Oncol; 1984 Aug; 7(4):357-60. PubMed ID: 6588746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of a new relapse treatment for acute myeloid leukemia (AML) on in vitro granulopoiesis.
    Müller MR; Sauter C; Erni J; Martz G
    Anticancer Res; 1983; 3(2):127-31. PubMed ID: 6573868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.